Brand-specific influenza vaccine effectiveness in the Nordic countries

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Feasibility analysis

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Name of medicine:
  INFLUVAC TETRA

  FLUCELVAX TETRA (--) - SUSPENSION FOR INJECTION

  FLUAD TETRA (--) - SUSPENSION FOR INJECTION
• Name of medicine, other:
  Vaxigrip Tetra, Efluelda Tetra

Study design details

• Main study objective:
  To document the feasibility of conducting annual brand-specific seasonal influenza vaccine effectiveness studies in Denmark, Finland, and Sweden.; ; To provide timely estimates of brand-specific seasonal influenza VE against laboratory-confirmed and influenza-related outcomes for the 2024-2025 season.